SEC Form 4 research
| Issuer | Seres Therapeutics, Inc. |
|---|---|
| Tickers | MCRB |
| Reporting owners | 50 |
| Officers and directors | 13 |
| Last public filing | 2026-08-19 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-18 | 2026-08-17 | Brady Kelly | S | 64 | $4.55 | Not reported |
| 2026-08-18 | 2026-08-17 | Shaff Eric D. | S | 263 | $4.55 | Not reported |
| 2026-08-18 | 2026-08-17 | Henn Matthew R | S | 81 | $4.55 | Not reported |
| 2026-08-18 | 2026-08-17 | DesRosier Thomas | S | 82 | $4.55 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.